Titan Pharmaceuticals Inc (TTNP)
6.97
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
7.31
+0.34
(+4.88%)
After-Hours: 20:00
Titan Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2021 | 80.00% |
| March 31, 2021 | 83.87% |
| December 31, 2020 | 67.34% |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | 80.15% |
| June 30, 2019 | 51.00% |
| March 31, 2019 | 67.83% |
| December 31, 2018 | 76.56% |
| September 30, 2018 | 89.21% |
| June 30, 2018 | 97.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
51.00%
Minimum
Jun 2019
83.87%
Maximum
Mar 2021
72.47%
Average
80.00%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| Outset Medical Inc | 25.28% |
| Allurion Technologies Inc | 78.08% |
| AIM ImmunoTech Inc | 81.54% |
| Protalix BioTherapeutics Inc | 15.54% |
| Armata Pharmaceuticals Inc | -- |